Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity

被引:85
作者
Berger, AL
Randak, CO
Ostedgaard, LS
Karp, PH
Vermeer, DW
Welsh, MJ
机构
[1] Univ Iowa, Dept Internal Med, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Phys & Biophys, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA
关键词
D O I
10.1074/jbc.M412972200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Compounds that enhance either the function or biosynthetic processing of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel may be of value in developing new treatments for cystic fibrosis (CF). Previous studies suggested that the herbal extract curcumin might affect the processing of a common CF mutant, CFTR-DeltaF508. Here, we tested the hypothesis that curcumin influences channel function. Curcumin increased CFTR channel activity in excised, inside-out membrane patches by reducing channel closed time and prolonging the time channels remained open. Stimulation was dose-dependent, reversible, and greater than that observed with genistein, another compound that stimulates CFTR. Curcumin-dependent stimulation required phosphorylated channels and the presence of ATP. We found that curcumin increased the activity of both wild-type and DeltaF508 channels. Adding curcumin also increased Cl- transport in differentiated non-CF airway epithelia but not in CF epithelia. These results suggest that curcumin may directly stimulate CFTR Cl- channels.
引用
收藏
页码:5221 / 5226
页数:6
相关论文
共 42 条
[1]
Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents [J].
Ai, T ;
Bompadre, SG ;
Wang, XH ;
Hu, SH ;
Li, M ;
Hwang, TC .
MOLECULAR PHARMACOLOGY, 2004, 65 (06) :1415-1426
[2]
Development of substituted benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel [J].
Becq, F ;
Mettey, Y ;
Gray, MA ;
Galietta, LJV ;
Dormer, RL ;
Merten, M ;
Métayé, T ;
Chappe, V ;
Marvingt-Mounir, C ;
Zegarra-Moran, O ;
Tarran, R ;
Bulteau, L ;
Dérand, R ;
Pereira, MMC ;
McPherson, MK ;
Rogier, C ;
Joffre, M ;
Argent, BE ;
Sarrouilhe, D ;
Kammouni, W ;
Figarella, C ;
Verrier, B ;
Gola, M ;
Vierfond, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) :27415-27425
[3]
Mutations that change the position of the putative γ-phosphate linker in the nucleotide binding domains of CFTR alter channel gating [J].
Berger, AL ;
Ikuma, M ;
Hunt, JF ;
Thomas, PJ ;
Welsh, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) :2125-2131
[4]
THE 2 NUCLEOTIDE-BINDING DOMAINS OF CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) HAVE DISTINCT FUNCTIONS IN CONTROLLING CHANNEL ACTIVITY [J].
CARSON, MR ;
TRAVIS, SM ;
WELSH, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (04) :1711-1717
[5]
MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].
CHILLON, M ;
CASALS, T ;
MERCIER, B ;
BASSAS, L ;
LISSENS, W ;
SILBER, S ;
ROMEY, MC ;
RUIZROMERO, J ;
VERLINGUE, C ;
CLAUSTRES, M ;
NUNES, V ;
FEREC, C ;
ESTIVILL, X .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1475-1480
[6]
EXTENSIVE POSTTRANSCRIPTIONAL DELETION OF THE CODING SEQUENCES FOR PART OF NUCLEOTIDE-BINDING FOLD-1 IN RESPIRATORY EPITHELIAL MESSENGER-RNA TRANSCRIPTS OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE IS NOT ASSOCIATED WITH THE CLINICAL MANIFESTATIONS OF CYSTIC-FIBROSIS [J].
CHU, CS ;
TRAPNELL, BC ;
CURRISTIN, SM ;
CUTTING, GR ;
CRYSTAL, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :785-790
[7]
Covalent modification of the nucleotide binding domains of cystic fibrosis transmembrane conductance regulator [J].
Cotten, JF ;
Welsh, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :31873-31879
[8]
The herd mentality and Russian studies [J].
David-Fox, M .
KRITIKA-EXPLORATIONS IN RUSSIAN AND EURASIAN HISTORY, 2001, 2 (01) :1-4
[9]
PROCESSING OF MUTANT CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IS TEMPERATURE-SENSITIVE [J].
DENNING, GM ;
ANDERSON, MP ;
AMARA, JF ;
MARSHALL, J ;
SMITH, AE ;
WELSH, MJ .
NATURE, 1992, 358 (6389) :761-764
[10]
The cystic fibrosis mutation G551D alters the non-Michaelis-Menten behavior of the cystic fibrosis transmembrane conductance regulator (CFTR) channel and abolishes the inhibitory genistein binding site [J].
Dérand, R ;
Bulteau-Pignoux, L ;
Becq, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :35999-36004